Bristol-Myers Squibb

Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
BioPharma Dive
Tue, 03/21/17 - 09:55 am
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Warfarin
A small drug company that's trying to make cancer treatments safer just received a $3.8 billion endorsement
Yahoo/Business Insider
Mon, 03/20/17 - 11:01 pm
CytomX
cancer immunotherapy
Bristol-Myers Squibb
Heat Biologics Lung Cancer Combo Succeeds
Investopedia
Mon, 03/13/17 - 04:38 pm
Heat Biologics
lung cancer
HS-110
Bristol-Myers Squibb
Opdivo
Bristol-Myers' R&D revamp mirrors upheaval in Opdivo's lung cancer fortunes
Fierce Pharma
Fri, 03/10/17 - 09:47 am
Bristol-Myers Squibb
R&D
Opdivo
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Fierce Pharma
Sat, 03/4/17 - 01:59 pm
Celgene
Novartis
Bristol-Myers Squibb
orphan drugs
Revlimid
Icahn hires on gene therapy legend—and big biotech disruptor—Richard Mulligan as Bristol-Myers rumors simmer
Endpoints
Thu, 03/2/17 - 09:40 am
Carl Icahn
gene therapy
Richard Mulligan
Bristol-Myers Squibb
Should Merck, BMS Fear Roche's Drug Becoming The I-O King?
Seeking Alpha
Fri, 02/24/17 - 09:10 am
Merck
Bristol-Myers Squibb
Roche
immuno-oncology
Tecentriq
How could you make a Bristol-Myers takeover work without shredding a $5B R&D division?
Endpoints
Thu, 02/23/17 - 09:24 pm
Bristol-Myers Squibb
R&D
M&A
Top 10 U.S. patent losses of 2017
Fierce Pharma
Thu, 02/23/17 - 09:29 am
patents
Copaxone
Cialis
Viagra
Velcade
Sustiva
Sandostatin LAR
Norditropin
Viread
Pristiq
Strattera
Pfizer
Teva
Takeda
Eli Lilly
Novartis
Bristol-Myers Squibb
Novo Nordisk
Gilead Sciences
Anyone really shopping for Bristol-Myers?
BioPharma Dive
Thu, 02/23/17 - 09:18 am
M&A
Bristol-Myers Squibb
JNJ
Pfizer
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Yahoo/Benzinga
Tue, 02/21/17 - 10:46 pm
Bristol-Myers Squibb
M&A
Carl Icahn
For Bristol Opdivo Gives And It Takes Away
Seeking Alpha
Fri, 02/17/17 - 09:53 am
Bristol-Myers Squibb
Opdivo
Bristol-Myers: Don’t Bet on a Pfizer Acquisition
Barron's
Thu, 02/16/17 - 10:07 am
Bristol-Myers Squibb
Pfizer
M&A
Bristol-Myers Squibb: Takeover Target?
Barron's
Tue, 02/14/17 - 07:35 pm
Bristol-Myers Squibb
M&A
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
AZ chief: Durvalumab's ready for a 'marketing battle' against I-O heavyweights Opdivo, Keytruda
Fierce Pharma
Tue, 02/7/17 - 10:25 am
immuno-oncology
AstraZeneca
durvalumab
Pascal Soriot
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Bristol-Myers, Innate's Lirilumab Fails Trial (BMY)
Investopedia
Mon, 02/6/17 - 11:16 am
Bristol-Myers Squibb
Innate Pharma S.A.
lirilumab
acute myeloid leukemia
FDA approves Bristol-Myers' Opdivo for bladder cancer
Yahoo/Reuters
Fri, 02/3/17 - 10:13 am
FDA
Bristol-Myers Squibb
Opdivo
bladder cancer
Merck Makes Nice With Bristol-Myers Squibb
Motley Fool
Tue, 01/31/17 - 10:07 am
Merck
Bristol-Myers Squibb
patents
Keytruda
Opdivo
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Bristol-Myers Squibb
Merck
Roche
Gilead Sciences

Pages